Refractory generalized myasthenia gravis

$Hopeful News for the European Refractory Generalized Myasthenia Gravis Community$

Hopeful News for the European Refractory Generalized Myasthenia Gravis Community

Post author:Patient Worthy Contributor
Post published:August 28, 2017
Post category:Myasthenia Gravis Rare Disease

This month, Soliris®, a treatment produced by Alexion Pharmaceuticals, Inc. was approved by the European Commission for the treatment of Refractory Generalized Myasthenia Gravis (gMG). Myasthenia gravis (MG) is a…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More